Risk factors

AIM ImmunoTech (AIM) risk factors

Item 1A of every AIM ImmunoTech Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open AIM in Gloom →
AIM ImmunoTech's chart, financials and news, free in your browser.Open AIM in Gloom →
  • FY2025 10-K risk factors
    42 risks2 new2 dropped3 reworded

    Accumulated deficit increased to approximately $440.8 million as of December 31, 2025.

    Filed Mar 27, 2026
  • FY2024 10-K risk factors
    42 risks

    This is an initial filing with no prior year comparison available. Biotechnology risks focus on cash burn, clinical trial execution, regulatory approvals, and manufacturing dependencies.

    Filed Mar 27, 2025